Article
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-mediated Tumor Immunotherapy
2022-11-08
Abstract excerpt
Traditional dendritic cell (DC)-mediated immunotherapy is usually suppressed by weak immunogenicity in tumors and generally leads to unsatisfactory outcomes. Synergistic exogenous/endogenous immunogenic activation can provide an alternative strategy for evoking a robust immune response by promoting DC activation. Herein, we prepared Ti 3 C 2 MXene-based nanoplatforms (termed MXP) with high-efficiency near-infrared...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 620a57ca-aa23-5063-97e6-8fd2ca9587e6
- DOI
- 10.21203/rs.3.rs-2021481/v1
